| References |
1. National Prion Disease Pathology Surveillance Center Report. 2. Parchi P, Giese A, Capellari S, Brown B, Schulz-Schaeffer W, Windl O, et al. Classification of Sporadic Creutzfeldt-Jakob Disease Based on Molecular and Phenotypic Analysis of 300 Subjects. Annals of Neurology. 46:224-233. 3. Yokota T, Tsuchiya K, Yamane M, Hayashi M, Tanabe H, Tsukagoshi H. Geotropic ocular deviation with skew and absence of saccade in Creutzfelt-Jakob disease. Journal of the Neurological Sciences. 106(2):175-8, 1991 Dec. 4. Helmchen C, Buttner U. Centripetal nystagmus in a case of Creutzfeldt-Jakob disease. Neuro-ophthalmology 1995; 15:187-192. 5. Brazis, PW, Biller, J, Masdeu, JC. Localization in Clinical Neurology. Fouth Edition. LWW. 2001. 6. Grant MP, Cohen M, Petersen RB, Halmagyi GM, McDougall A, Tusa RJ, Leigh RJ. Abnormal ye movements in Creutzfeldt-Jakob Disease. Annals of Neurology. 34(2):192-7, 1993 Aug. 7. Bertoni JM, Brown P, Goldfarb LG, Rubenstein R, Gajdusek DC. Familial Creutzfeldt-Jakob Disease (codon 200 mutation) with supranuclear palsy.JAMA. 268(17):2413-5. 8. Johnson, RT, Gibbs, CJ. Creutzfeldt-Jakob Disease and Related Transmissible Spongiform Encephalopathies. New England Journal of Medicine. Vol 339(27): 1994-2004. 9. Beaudry P, Cohen P, Brandel JP, et al. 14-3-3 Protein, neuron-specific enolase, and the S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob Disease. Dement Geriatr Cogn Disord. Vol.10:40-46. 10. Hsich G, Kenney K, Gibbs CH, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. New England Journal of Medicine. Vol 335: 924-930. 11. Poser, S, Mollenhauer B, Kraubeta A, et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob Disease. Brain. Vol.122:2345-2351. 12. Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, Gaskin D, et al. Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creuztfeldt-Jakob Disease. Archives of Neurology. Vol. 60: 813-816. 13. Aksamit AJ. Cerebrospinal Fluid 14-3-3 Protein: Variability of Sporadic Creutzfeldt-Jakob Disease, Laboratory Standards, and Quantitation. Archives of Neurology. Vol. 60: 803-804. 14. Schroter A, Zerr I, Henkl K, et al. Magnetic Resonance Imaging in the Clinical Diagnosis of Creutzfeldt-Jakob Disease. Archives of Neurology. Vol. 57: 1751-1757. 15. Vrancken AFJE, Frijns CJM, Ramos LMP. FLAIR MRI in sporadic Creutzfeldt-Jakob Disease. Neurology. Vol 55: 147. 16. Demaerel P, Heiner L, Robberecht W, Sciot R, Wilms G. Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob Disease. Neurology. Vol 52: 205-207. 17. Urbach H, Klisch J, Wolf HK, et al. MRI in sporadic Creutzfeldt-Jakob Disease: Correlation with clinical and neuropathological data. Neuroradiology. Vol 40:65-70. 18. Levy, SR, Chiappa, KH, Burke, CJ, Young, RR. Early Evolution and Incidence of Electroencephalographic Abnormalities in Creutzfeldt-Jakob Disease. Journal of Clinical Neurophysiology. 3 (1):1-21. |
